Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Inhibition of glutathione (GSH) synthesis in cancer cells considerably improves the efficacy of reactive oxygen species (ROS)‐related tumor therapy. Self‐assembled peptide derivatives can facilitate the efficient delivery and accumulation of small molecular drugs in cancer cells.
Self‐assembling modules were covalently linked to the GSH‐ biosynthesis inhibitor L‐buthionine sulfoximine (BSO) by solid‐phase synthesis to form the self‐assembling peptide derivative Nap‐DFDFpY‐GG‐BSO (Nano‐BSO@ in situ). Subsequently, its enzyme‐instructed self‐assembly in vitro and on cell surfaces were confirmed, and its intracellular GSH depletion and radiotherapy‐sensitizing effects were determined.
Nano‐BSO@ in situ successfully self‐assembles into a hydrogel with a nanofibrous microstructure upon incubation with alkaline phosphatase (ALP) at a critical concentration of 9.84 μM. Furthermore, it selectively self‐assembles in situ on HeLa cells with high ALP expression. At a concentration of 50 μM, Nano‐BSO@ in situ decreases intracellular GSH levels by 80%, ~2.3 times more than free BSO. Meanwhile, pretreatment of HeLa cells with 50 μM Nano‐BSO@ in situ for 24 h results in a radiotherapy sensitization enhancement ratio to γ‐rays of 2.09.
A novel in situ self‐assembling peptide derivative for GSH depletion and selective enhancement of tumor radiotherapy was constructed. The excellent GSH‐depletion ability and remarkable radiotherapy‐enhancement performance indicate that Nano‐BSO@ in situ is a promising selective sensitizer for ROS‐related treatment of tumor cells with high ALP expression.
Cadet J, Wagner JR. DNA base damage by reactive oxygen species, oxidizing agents, and UV radiation. Cold Spring Harbor Perspect Biol. 2013;5(2):a012559. https://doi.org/10.1101/cshperspect.a012559
Nass K. Radiation damage in protein crystallography at X‐ray free‐electron lasers. Acta Crystallogr D Struct Biol. 2019;75(Pt 2):211–218. https://doi.org/10.1107/s2059798319000317
Ahmed M, Ahmed R. Radiation in gastroenterology. Gastroenterol Res. 2022;15(6):285–296. https://doi.org/10.14740/gr1567
Hall S, Rudrawar S, Zunk M, Bernaitis N, Arora D, McDermott C, et al. Protection against radiotherapy‐induced toxicity. Antioxidants. 2016;5(3):22. https://doi.org/10.3390/antiox5030022
Guo X, Cheng Y, Zhao X, Luo Y, Chen J, Yuan WE. Advances in redox‐responsive drug delivery systems of tumor microenvironment. J Nanobiotechnol. 2018;16(1):74. https://doi.org/10.1186/s12951-018-0398-2
Liu R, Bian Y, Liu L, Liu L, Liu X, Ma S. Molecular pathways associated with oxidative stress and their potential applications in radiotherapy (Review). Int J Mol Med. 2022;49(5):65. https://doi.org/10.3892/ijmm.2022.5121
Lan M, Zhao S, Liu W, Lee CS, Zhang W, Wang P. Photosensitizers for photodynamic therapy. Adv Healthcare Mater. 2019;8(13):e1900132. https://doi.org/10.1002/adhm.201900132
Xin J, Deng C, Aras O, Zhou M, Wu C, An F. Chemodynamic nanomaterials for cancer theranostics. J Nanobiotechnol. 2021;19(1):192. https://doi.org/10.1186/s12951-021-00936-y
Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17(9):2054–81. https://doi.org/10.1080/15548627.2020.1810918
Liu B, Bian Y, Yuan M, Zhu Y, Liu S, Ding H, et al. L‐buthionine sulfoximine encapsulated hollow calcium peroxide as a chloroperoxidase nanocarrier for enhanced enzyme dynamic therapy. Biomaterials. 2022;289:121746. https://doi.org/10.1016/j.biomaterials.2022.121746
Lee H, To NB, Kim M, Nguyen YT, Cho SK, Choi HK. Metabolic and lipidomic characterization of radioresistant MDA‐MB‐231 human breast cancer cells to investigate potential therapeutic targets. J Pharm Biomed Anal. 2022;208:114449. https://doi.org/10.1016/j.jpba.2021.114449
Liu T, Xiong CF, Zhang LJ, Jiao G, Shi H, Feng J, et al. Boosting doxorubicin‐induced mitochondria apoptosis for the monodrug‐mediated combination of chemotherapy and chemodynamic therapy. Adv Healthcare Mater. 2023;12(3):e2202045. https://doi.org/10.1002/adhm.202202045
Zheng Y, Wang W, Gao Y, Zhang R, Wu D, Yu L, et al. Nanosonosensitizers‐engineered injectable thermogel for augmented chemo‐sonodynamic therapy of melanoma and infected wound healing. Mater Today Bio. 2023;20:100621. https://doi.org/10.1016/j.mtbio.2023.100621
Cai PY, Ma ML, Zhang YF, Zhou ZX, Wang Y, He LP, et al. Inhibition of glutathione metabolism can limit the development of pancreatic cancer. World J Stem Cell. 2022;14(5):362–4. https://doi.org/10.4252/wjsc.v14.i5.362
Kitching M, Inguva S, Ramani M, Gao Y, Marsili E, Cahill P. Biosynthesis of gold nanoparticles by vascular cells in vitro. Front Microbiol. 2022;13:813511. https://doi.org/10.3389/fmicb.2022.813511
Wei Y, Wang Z, Yang J, Xu R, Deng H, Ma S, et al. Reactive oxygen species/photothermal therapy dual‐triggered biomimetic gold nanocages nanoplatform for combination cancer therapy via ferroptosis and tumor‐associated macrophage repolarization mechanism. J Colloid Interface Sci. 2022;606(Pt 2):1950–1965. https://doi.org/10.1016/j.jcis.2021.09.160
Zhu J, Jiao A, Li Q, Lv X, Wang X, Song X, et al. Mitochondrial Ca2+‐overloading by oxygen/glutathione depletion‐boosted photodynamic therapy based on a CaCO3 nanoplatform for tumor synergistic therapy. Acta Biomater. 2022;137:252–61. https://doi.org/10.1016/j.actbio.2021.10.016
Xu J, Zhang J, Song J, Liu Y, Li J, Wang X, et al. Construction of multifunctional mesoporous silicon nano‐drug delivery system and study of dual sensitization of chemo‐photodynamic therapy in vitro and in vivo. J Colloid Interface Sci. 2022;628(Pt B):271–85. https://doi.org/10.1016/j.jcis.2022.08.100
Wang H, Yang W, Bian K, Zeng W, Jin X, Ouyang R, et al. Oxygen‐deficient BiOCl combined with l‐buthionine‐sulfoximine synergistically suppresses tumor growth through enhanced singlet oxygen generation under ultrasound irradiation. Small. 2022;18(9):e2104550. https://doi.org/10.1002/smll.202104550
Yang Z, Qiao C, Jia Q, Chen Z, Wang X, liu X, et al. Redox dyshomeostasis modulation of the tumor intracellular environment through a metabolic intervention strategy for enhanced photodynamic therapy. Theranostics. 2022;12(14):6143–54. https://doi.org/10.7150/thno.75837
Yu J, Xiao H, Yang Z, Qiao C, Zhou B, Jia Q, et al. A potent strategy of combinational blow toward enhanced cancer chemo‐photodynamic therapy via sustainable GSH elimination. Small. 2022;18(9):e2106100. https://doi.org/10.1002/smll.202106100
Pei Z, Lei H, Cheng L. Bioactive inorganic nanomaterials for cancer theranostics. Chem Soc Rev. 2023;52(6):2031–81. https://doi.org/10.1039/d2cs00352j
Yang Y, Yang T, Chen F, Zhang C, Yin B, Yin X, et al. Degradable magnetic nanoplatform with hydroxide ions triggered photoacoustic, MR imaging, and photothermal conversion for precise cancer theranostic. Nano Lett. 2022;22(8):3228–35. https://doi.org/10.1021/acs.nanolett.1c04804
Tang L, Zhang A, Zhang Z, Zhao Q, Li J, Mei Y, et al. Multifunctional inorganic nanomaterials for cancer photoimmunotherapy. Cancer Commun. 2022;42(2):141–63. https://doi.org/10.1002/cac2.12255
Kang Y, Wang S, Fan J, Peng X. Progress in inorganic nanomedicine carriers for tumor diagnosis and treatments. CIESC J. 2018;69(1):128–40.
Liu N, Zhu L, Li Z, Liu W, Sun M, Zhou Z. In situ self‐assembled peptide nanofibers for cancer theranostics. Biomater Sci. 2021;9(16):5427–36. https://doi.org/10.1039/d1bm00782c
Morita K, Nishimura K, Yamamoto S, Shimizu N, Yashiro T, Kawabata R, et al. In situ synthesis of an anticancer peptide amphiphile using tyrosine kinase overexpressed in cancer cells. JACS Au. 2022;2(9):2023–8. https://doi.org/10.1021/jacsau.2c00301
Gao Y, Li Y, Cao H, Jia H, Wang D, Ren C, et al. Hypertoxic self‐assembled peptide with dual functions of glutathione depletion and biosynthesis inhibition for selective tumor ferroptosis and pyroptosis. J Nanobiotechnol. 2022;20(1):390. https://doi.org/10.1186/s12951-022-01604-5
Zhou J, Xu B. Enzyme‐instructed self‐assembly: a multistep process for potential cancer therapy. Bioconjugate Chem. 2015;26(6):987–99. https://doi.org/10.1021/acs.bioconjchem.5b00196
Li X, Wang Y, Zhang Y, Yang Z, Gao J, Shi Y. Enzyme‐instructed self‐assembly (EISA) assists the self‐assembly and hydrogelation of hydrophobic peptides. J Mater Chem B. 2022;10(17):3242–7. https://doi.org/10.1039/d2tb00182a
Gong Z, Zhou B, Liu X, Cao J, Hong Z, Wang J, et al. Enzyme‐induced transformable peptide nanocarriers with enhanced drug permeability and retention to improve tumor nanotherapy efficacy. ACS Appl Mater Interfaces. 2021;13(47):55913–27. https://doi.org/10.1021/acsami.1c17917
Xie L, Ding Y, Zhang X, Zhang Z, Zeng S, Wang L, et al. A cascade‐targeted enzyme‐instructed peptide self‐assembly strategy for cancer immunotherapy through boosting immunogenic cell death. Small Methods. 2023;7(5):e2201416. https://doi.org/10.1002/smtd.202201416
Ji S, Gao H, Mu W, Ni X, Yi X, Shen J, et al. Enzyme‐instructed self‐assembly leads to the activation of optical properties for selective fluorescence detection and photodynamic ablation of cancer cells. J Mater Chem B. 2018;6(17):2566–73. https://doi.org/10.1039/c7tb02685d
Tesauro D, Accardo A, Diaferia C, Milano V, Guillon J, Ronga L, et al. Peptide‐based drug‐delivery systems in biotechnological applications: recent advances and perspectives. Molecules. 2019;24(2):351. https://doi.org/10.3390/molecules24020351
Tan W, Zhang Q, Wang J, Yi M, He H, Xu B. Enzymatic assemblies of thiophosphopeptides instantly target Golgi apparatus and selectively kill cancer cells. Angew Chem Int Ed. 2021;60(23):12796–801. https://doi.org/10.1002/anie.202102601
Hou X, Yang L, Li P, Liu J, Zhang Y, Wang Q, et al. In situ self‐assembly supramolecular antagonist reinforces radiotherapy by inhibiting tumor apoptosis evasion. Adv Funct Mater. 2023;33:2302697. https://doi.org/10.1002/adfm.202302697
Luo Y, Yan P, Li X, Hou J, Wang Y, Zhou S. pH‐sensitive polymeric vesicles for GOx/BSO delivery and synergetic starvation‐ferroptosis therapy of tumor. Biomacromolecules. 2021;22(10):4383–94. https://doi.org/10.1021/acs.biomac.1c00960
Zhong H, Huang PY, Yan P, Chen P, Shi Q, Zhao Z, et al. Versatile nanodrugs containing glutathione and heme oxygenase 1 inhibitors enable suppression of antioxidant defense system in a two‐pronged manner for enhanced photodynamic therapy. Adv Healthcare Mater. 2021;10(19):e2100770. https://doi.org/10.1002/adhm.202100770
Xiong Y, Xiao C, Li Z, Yang X. Engineering nanomedicine for glutathione depletion‐augmented cancer therapy. Chem Soc Rev. 2021;50(10):6013–41. https://doi.org/10.1039/d0cs00718h
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.